Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
29.43
0.00 (0.00%)
Aug 24, 2026, 9:31 AM EDT - Market open
Maze Therapeutics Revenue
Maze Therapeutics had revenue of $20.00M in the twelve months ending June 30, 2026, up 700.00% year-over-year.
Revenue (ttm)
$20.00M
Revenue Growth
+700.00%
P/S Ratio
81.74
Revenue / Employee
$141,844
Employees
141
Market Cap
1.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
MAZE News
- 10 days ago - Maze Therapeutics Announces Appointments to Its Board of Directors - GlobeNewsWire
- 12 days ago - Maze Therapeutics reports Q2 EPS (76c), consensus (70c) - TheFly
- 12 days ago - Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 12 days ago - Maze Therapeutics Earnings release: Q2 2026 - Filings
- 12 days ago - Maze Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Maze Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Maze Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts